nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP2A6—Amobarbital—epilepsy syndrome	0.0365	0.053	CbGbCtD
Norfloxacin—CYP2A6—Propofol—epilepsy syndrome	0.0272	0.0395	CbGbCtD
Norfloxacin—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0266	0.0385	CbGbCtD
Norfloxacin—CYP2A6—Phenobarbital—epilepsy syndrome	0.026	0.0377	CbGbCtD
Norfloxacin—SLC22A5—Valproic Acid—epilepsy syndrome	0.0256	0.0371	CbGbCtD
Norfloxacin—CYP1A1—Propofol—epilepsy syndrome	0.0233	0.0337	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0223	0.0323	CbGbCtD
Norfloxacin—CYP3A7—Carbamazepine—epilepsy syndrome	0.0223	0.0323	CbGbCtD
Norfloxacin—CYP1A1—Phenobarbital—epilepsy syndrome	0.0222	0.0322	CbGbCtD
Norfloxacin—CYP3A7—Phenytoin—epilepsy syndrome	0.02	0.0289	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.02	0.0289	CbGbCtD
Norfloxacin—SLC22A6—Acetazolamide—epilepsy syndrome	0.0195	0.0283	CbGbCtD
Norfloxacin—CYP2A6—Valproic Acid—epilepsy syndrome	0.0194	0.0282	CbGbCtD
Norfloxacin—CYP3A7—Phenobarbital—epilepsy syndrome	0.0178	0.0258	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0178	0.0258	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0175	0.0254	CbGbCtD
Norfloxacin—CYP3A7—Midazolam—epilepsy syndrome	0.0175	0.0254	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0169	0.0245	CbGbCtD
Norfloxacin—CYP3A7—Diazepam—epilepsy syndrome	0.0169	0.0245	CbGbCtD
Norfloxacin—CYP3A5—Carbamazepine—epilepsy syndrome	0.0167	0.0242	CbGbCtD
Norfloxacin—CYP3A5—Phenytoin—epilepsy syndrome	0.015	0.0217	CbGbCtD
Norfloxacin—SLC22A6—Valproic Acid—epilepsy syndrome	0.0146	0.0211	CbGbCtD
Norfloxacin—CYP3A5—Phenobarbital—epilepsy syndrome	0.0133	0.0194	CbGbCtD
Norfloxacin—CYP3A5—Midazolam—epilepsy syndrome	0.0132	0.0191	CbGbCtD
Norfloxacin—CYP3A5—Diazepam—epilepsy syndrome	0.0127	0.0183	CbGbCtD
Norfloxacin—CYP1A2—Carbamazepine—epilepsy syndrome	0.0124	0.018	CbGbCtD
Norfloxacin—CYP1A2—Primidone—epilepsy syndrome	0.0116	0.0168	CbGbCtD
Norfloxacin—CYP1A2—Propofol—epilepsy syndrome	0.0104	0.0151	CbGbCtD
Norfloxacin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0104	0.015	CbGbCtD
Norfloxacin—CYP3A5—Valproic Acid—epilepsy syndrome	0.00997	0.0145	CbGbCtD
Norfloxacin—CYP1A2—Phenobarbital—epilepsy syndrome	0.00993	0.0144	CbGbCtD
Norfloxacin—CYP3A4—Trimethadione—epilepsy syndrome	0.00964	0.014	CbGbCtD
Norfloxacin—CYP3A4—Felbamate—epilepsy syndrome	0.00964	0.014	CbGbCtD
Norfloxacin—CYP1A2—Diazepam—epilepsy syndrome	0.00942	0.0137	CbGbCtD
Norfloxacin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00906	0.0131	CbGbCtD
Norfloxacin—CYP3A4—Clonazepam—epilepsy syndrome	0.00819	0.0119	CbGbCtD
Norfloxacin—CYP3A4—Clobazam—epilepsy syndrome	0.00786	0.0114	CbGbCtD
Norfloxacin—CYP1A2—Valproic Acid—epilepsy syndrome	0.00742	0.0108	CbGbCtD
Norfloxacin—CYP3A4—Rufinamide—epilepsy syndrome	0.00668	0.00969	CbGbCtD
Norfloxacin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00651	0.00944	CbGbCtD
Norfloxacin—CYP3A4—Primidone—epilepsy syndrome	0.00608	0.00881	CbGbCtD
Norfloxacin—CYP3A4—Phenytoin—epilepsy syndrome	0.00584	0.00847	CbGbCtD
Norfloxacin—CYP3A4—Propofol—epilepsy syndrome	0.00545	0.0079	CbGbCtD
Norfloxacin—CYP3A4—Phenobarbital—epilepsy syndrome	0.0052	0.00755	CbGbCtD
Norfloxacin—CYP3A4—Acetazolamide—epilepsy syndrome	0.0052	0.00755	CbGbCtD
Norfloxacin—CYP3A4—Midazolam—epilepsy syndrome	0.00513	0.00744	CbGbCtD
Norfloxacin—CYP3A4—Diazepam—epilepsy syndrome	0.00493	0.00715	CbGbCtD
Norfloxacin—CYP3A4—Zonisamide—epilepsy syndrome	0.00482	0.00698	CbGbCtD
Norfloxacin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00389	0.00564	CbGbCtD
Norfloxacin—CYP3A4—Topiramate—epilepsy syndrome	0.00351	0.00509	CbGbCtD
Norfloxacin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00227	0.768	CbGdCrCtD
Norfloxacin—Lomefloxacin—ABCC2—epilepsy syndrome	0.000437	0.313	CrCbGaD
Norfloxacin—Ofloxacin—ABCC2—epilepsy syndrome	0.000373	0.268	CrCbGaD
Norfloxacin—Gatifloxacin—ALB—epilepsy syndrome	0.000313	0.225	CrCbGaD
Norfloxacin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.0003	0.101	CbGdCrCtD
Norfloxacin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000208	0.0703	CbGdCrCtD
Norfloxacin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000178	0.0603	CbGdCrCtD
Norfloxacin—Levofloxacin—ABCB1—epilepsy syndrome	0.000137	0.0986	CrCbGaD
Norfloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000133	0.0952	CrCbGaD
Norfloxacin—Nausea—Propofol—epilepsy syndrome	6.68e-05	0.00026	CcSEcCtD
Norfloxacin—Tension—Gabapentin—epilepsy syndrome	6.66e-05	0.00026	CcSEcCtD
Norfloxacin—Vomiting—Fosphenytoin—epilepsy syndrome	6.66e-05	0.00026	CcSEcCtD
Norfloxacin—Diarrhoea—Felbamate—epilepsy syndrome	6.66e-05	0.00026	CcSEcCtD
Norfloxacin—Vertigo—Pregabalin—epilepsy syndrome	6.65e-05	0.00026	CcSEcCtD
Norfloxacin—Body temperature increased—Lamotrigine—epilepsy syndrome	6.65e-05	0.000259	CcSEcCtD
Norfloxacin—Abdominal pain—Lamotrigine—epilepsy syndrome	6.65e-05	0.000259	CcSEcCtD
Norfloxacin—Dysgeusia—Gabapentin—epilepsy syndrome	6.65e-05	0.000259	CcSEcCtD
Norfloxacin—Dizziness—Diazepam—epilepsy syndrome	6.65e-05	0.000259	CcSEcCtD
Norfloxacin—Leukopenia—Pregabalin—epilepsy syndrome	6.63e-05	0.000259	CcSEcCtD
Norfloxacin—Rash—Fosphenytoin—epilepsy syndrome	6.61e-05	0.000258	CcSEcCtD
Norfloxacin—Dermatitis—Fosphenytoin—epilepsy syndrome	6.6e-05	0.000258	CcSEcCtD
Norfloxacin—Nervousness—Gabapentin—epilepsy syndrome	6.6e-05	0.000257	CcSEcCtD
Norfloxacin—Asthenia—Clonazepam—epilepsy syndrome	6.59e-05	0.000257	CcSEcCtD
Norfloxacin—Back pain—Gabapentin—epilepsy syndrome	6.57e-05	0.000256	CcSEcCtD
Norfloxacin—Headache—Fosphenytoin—epilepsy syndrome	6.56e-05	0.000256	CcSEcCtD
Norfloxacin—Hepatitis—Topiramate—epilepsy syndrome	6.56e-05	0.000256	CcSEcCtD
Norfloxacin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.55e-05	0.000255	CcSEcCtD
Norfloxacin—Palpitations—Pregabalin—epilepsy syndrome	6.54e-05	0.000255	CcSEcCtD
Norfloxacin—Asthenia—Phenytoin—epilepsy syndrome	6.54e-05	0.000255	CcSEcCtD
Norfloxacin—Nausea—Midazolam—epilepsy syndrome	6.53e-05	0.000255	CcSEcCtD
Norfloxacin—Hallucination—Topiramate—epilepsy syndrome	6.53e-05	0.000255	CcSEcCtD
Norfloxacin—Hypoaesthesia—Topiramate—epilepsy syndrome	6.53e-05	0.000255	CcSEcCtD
Norfloxacin—Muscle spasms—Gabapentin—epilepsy syndrome	6.53e-05	0.000255	CcSEcCtD
Norfloxacin—Diarrhoea—Zonisamide—epilepsy syndrome	6.52e-05	0.000254	CcSEcCtD
Norfloxacin—Asthenia—Oxcarbazepine—epilepsy syndrome	6.51e-05	0.000254	CcSEcCtD
Norfloxacin—Pruritus—Clonazepam—epilepsy syndrome	6.5e-05	0.000253	CcSEcCtD
Norfloxacin—Vomiting—Vigabatrin—epilepsy syndrome	6.49e-05	0.000253	CcSEcCtD
Norfloxacin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.46e-05	0.000252	CcSEcCtD
Norfloxacin—Pruritus—Phenytoin—epilepsy syndrome	6.45e-05	0.000252	CcSEcCtD
Norfloxacin—Nausea—Levetiracetam—epilepsy syndrome	6.45e-05	0.000252	CcSEcCtD
Norfloxacin—Rash—Vigabatrin—epilepsy syndrome	6.44e-05	0.000251	CcSEcCtD
Norfloxacin—Dizziness—Felbamate—epilepsy syndrome	6.44e-05	0.000251	CcSEcCtD
Norfloxacin—Dermatitis—Vigabatrin—epilepsy syndrome	6.43e-05	0.000251	CcSEcCtD
Norfloxacin—Pruritus—Oxcarbazepine—epilepsy syndrome	6.42e-05	0.00025	CcSEcCtD
Norfloxacin—Convulsion—Pregabalin—epilepsy syndrome	6.42e-05	0.00025	CcSEcCtD
Norfloxacin—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.41e-05	0.00025	CcSEcCtD
Norfloxacin—Vision blurred—Gabapentin—epilepsy syndrome	6.4e-05	0.00025	CcSEcCtD
Norfloxacin—Headache—Vigabatrin—epilepsy syndrome	6.4e-05	0.00025	CcSEcCtD
Norfloxacin—Vomiting—Diazepam—epilepsy syndrome	6.39e-05	0.000249	CcSEcCtD
Norfloxacin—Anorexia—Valproic Acid—epilepsy syndrome	6.37e-05	0.000249	CcSEcCtD
Norfloxacin—Tremor—Gabapentin—epilepsy syndrome	6.36e-05	0.000248	CcSEcCtD
Norfloxacin—Rash—Diazepam—epilepsy syndrome	6.34e-05	0.000247	CcSEcCtD
Norfloxacin—Dermatitis—Diazepam—epilepsy syndrome	6.33e-05	0.000247	CcSEcCtD
Norfloxacin—Visual impairment—Topiramate—epilepsy syndrome	6.32e-05	0.000247	CcSEcCtD
Norfloxacin—Myalgia—Pregabalin—epilepsy syndrome	6.31e-05	0.000246	CcSEcCtD
Norfloxacin—Arthralgia—Pregabalin—epilepsy syndrome	6.31e-05	0.000246	CcSEcCtD
Norfloxacin—Chest pain—Pregabalin—epilepsy syndrome	6.31e-05	0.000246	CcSEcCtD
Norfloxacin—Dizziness—Zonisamide—epilepsy syndrome	6.3e-05	0.000246	CcSEcCtD
Norfloxacin—Headache—Diazepam—epilepsy syndrome	6.3e-05	0.000246	CcSEcCtD
Norfloxacin—Anxiety—Pregabalin—epilepsy syndrome	6.28e-05	0.000245	CcSEcCtD
Norfloxacin—Diarrhoea—Clonazepam—epilepsy syndrome	6.28e-05	0.000245	CcSEcCtD
Norfloxacin—Asthenia—Carbamazepine—epilepsy syndrome	6.25e-05	0.000244	CcSEcCtD
Norfloxacin—Agitation—Gabapentin—epilepsy syndrome	6.24e-05	0.000243	CcSEcCtD
Norfloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	6.24e-05	0.000243	CcSEcCtD
Norfloxacin—Nausea—Fosphenytoin—epilepsy syndrome	6.22e-05	0.000243	CcSEcCtD
Norfloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.21e-05	0.000242	CcSEcCtD
Norfloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	6.21e-05	0.000242	CcSEcCtD
Norfloxacin—Angioedema—Gabapentin—epilepsy syndrome	6.21e-05	0.000242	CcSEcCtD
Norfloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.2e-05	0.000242	CcSEcCtD
Norfloxacin—Vomiting—Felbamate—epilepsy syndrome	6.19e-05	0.000241	CcSEcCtD
Norfloxacin—Dry mouth—Pregabalin—epilepsy syndrome	6.17e-05	0.000241	CcSEcCtD
Norfloxacin—Pruritus—Carbamazepine—epilepsy syndrome	6.16e-05	0.00024	CcSEcCtD
Norfloxacin—Rash—Felbamate—epilepsy syndrome	6.14e-05	0.000239	CcSEcCtD
Norfloxacin—Dermatitis—Felbamate—epilepsy syndrome	6.13e-05	0.000239	CcSEcCtD
Norfloxacin—Tinnitus—Topiramate—epilepsy syndrome	6.12e-05	0.000239	CcSEcCtD
Norfloxacin—Vertigo—Gabapentin—epilepsy syndrome	6.1e-05	0.000238	CcSEcCtD
Norfloxacin—Headache—Felbamate—epilepsy syndrome	6.1e-05	0.000238	CcSEcCtD
Norfloxacin—Confusional state—Pregabalin—epilepsy syndrome	6.09e-05	0.000238	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.09e-05	0.000238	CcSEcCtD
Norfloxacin—Leukopenia—Gabapentin—epilepsy syndrome	6.08e-05	0.000237	CcSEcCtD
Norfloxacin—Dizziness—Clonazepam—epilepsy syndrome	6.07e-05	0.000237	CcSEcCtD
Norfloxacin—Nausea—Vigabatrin—epilepsy syndrome	6.07e-05	0.000237	CcSEcCtD
Norfloxacin—Vomiting—Zonisamide—epilepsy syndrome	6.06e-05	0.000236	CcSEcCtD
Norfloxacin—Insomnia—Valproic Acid—epilepsy syndrome	6.05e-05	0.000236	CcSEcCtD
Norfloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.04e-05	0.000236	CcSEcCtD
Norfloxacin—Oedema—Pregabalin—epilepsy syndrome	6.04e-05	0.000236	CcSEcCtD
Norfloxacin—Asthenia—Lamotrigine—epilepsy syndrome	6.04e-05	0.000236	CcSEcCtD
Norfloxacin—Dizziness—Phenytoin—epilepsy syndrome	6.03e-05	0.000235	CcSEcCtD
Norfloxacin—Rash—Zonisamide—epilepsy syndrome	6.01e-05	0.000234	CcSEcCtD
Norfloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	6e-05	0.000234	CcSEcCtD
Norfloxacin—Palpitations—Gabapentin—epilepsy syndrome	6e-05	0.000234	CcSEcCtD
Norfloxacin—Dermatitis—Zonisamide—epilepsy syndrome	6e-05	0.000234	CcSEcCtD
Norfloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	6e-05	0.000234	CcSEcCtD
Norfloxacin—Nausea—Diazepam—epilepsy syndrome	5.97e-05	0.000233	CcSEcCtD
Norfloxacin—Headache—Zonisamide—epilepsy syndrome	5.97e-05	0.000233	CcSEcCtD
Norfloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	5.96e-05	0.000233	CcSEcCtD
Norfloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	5.96e-05	0.000232	CcSEcCtD
Norfloxacin—Pruritus—Lamotrigine—epilepsy syndrome	5.95e-05	0.000232	CcSEcCtD
Norfloxacin—Somnolence—Valproic Acid—epilepsy syndrome	5.94e-05	0.000232	CcSEcCtD
Norfloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.92e-05	0.000231	CcSEcCtD
Norfloxacin—Chills—Topiramate—epilepsy syndrome	5.89e-05	0.00023	CcSEcCtD
Norfloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	5.89e-05	0.00023	CcSEcCtD
Norfloxacin—Convulsion—Gabapentin—epilepsy syndrome	5.88e-05	0.00023	CcSEcCtD
Norfloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.84e-05	0.000228	CcSEcCtD
Norfloxacin—Vomiting—Clonazepam—epilepsy syndrome	5.84e-05	0.000228	CcSEcCtD
Norfloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	5.81e-05	0.000227	CcSEcCtD
Norfloxacin—Vomiting—Phenytoin—epilepsy syndrome	5.8e-05	0.000226	CcSEcCtD
Norfloxacin—Rash—Clonazepam—epilepsy syndrome	5.79e-05	0.000226	CcSEcCtD
Norfloxacin—Dermatitis—Clonazepam—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Norfloxacin—Arthralgia—Gabapentin—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Norfloxacin—Myalgia—Gabapentin—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Norfloxacin—Chest pain—Gabapentin—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Norfloxacin—Nausea—Felbamate—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Norfloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	5.77e-05	0.000225	CcSEcCtD
Norfloxacin—Fatigue—Valproic Acid—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Norfloxacin—Anxiety—Gabapentin—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Norfloxacin—Anorexia—Pregabalin—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Norfloxacin—Dizziness—Carbamazepine—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Norfloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Norfloxacin—Headache—Clonazepam—epilepsy syndrome	5.75e-05	0.000224	CcSEcCtD
Norfloxacin—Rash—Phenytoin—epilepsy syndrome	5.75e-05	0.000224	CcSEcCtD
Norfloxacin—Dermatitis—Phenytoin—epilepsy syndrome	5.75e-05	0.000224	CcSEcCtD
Norfloxacin—Rash—Oxcarbazepine—epilepsy syndrome	5.72e-05	0.000223	CcSEcCtD
Norfloxacin—Constipation—Valproic Acid—epilepsy syndrome	5.72e-05	0.000223	CcSEcCtD
Norfloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000223	CcSEcCtD
Norfloxacin—Headache—Phenytoin—epilepsy syndrome	5.71e-05	0.000223	CcSEcCtD
Norfloxacin—Erythema—Topiramate—epilepsy syndrome	5.71e-05	0.000223	CcSEcCtD
Norfloxacin—Headache—Oxcarbazepine—epilepsy syndrome	5.68e-05	0.000222	CcSEcCtD
Norfloxacin—Nausea—Zonisamide—epilepsy syndrome	5.66e-05	0.000221	CcSEcCtD
Norfloxacin—Dry mouth—Gabapentin—epilepsy syndrome	5.65e-05	0.000221	CcSEcCtD
Norfloxacin—Flatulence—Topiramate—epilepsy syndrome	5.63e-05	0.00022	CcSEcCtD
Norfloxacin—Tension—Topiramate—epilepsy syndrome	5.61e-05	0.000219	CcSEcCtD
Norfloxacin—Dysgeusia—Topiramate—epilepsy syndrome	5.59e-05	0.000218	CcSEcCtD
Norfloxacin—Confusional state—Gabapentin—epilepsy syndrome	5.59e-05	0.000218	CcSEcCtD
Norfloxacin—Dizziness—Lamotrigine—epilepsy syndrome	5.56e-05	0.000217	CcSEcCtD
Norfloxacin—Nervousness—Topiramate—epilepsy syndrome	5.55e-05	0.000216	CcSEcCtD
Norfloxacin—Oedema—Gabapentin—epilepsy syndrome	5.54e-05	0.000216	CcSEcCtD
Norfloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.54e-05	0.000216	CcSEcCtD
Norfloxacin—Vomiting—Carbamazepine—epilepsy syndrome	5.54e-05	0.000216	CcSEcCtD
Norfloxacin—Back pain—Topiramate—epilepsy syndrome	5.53e-05	0.000216	CcSEcCtD
Norfloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.51e-05	0.000215	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.51e-05	0.000215	CcSEcCtD
Norfloxacin—Muscle spasms—Topiramate—epilepsy syndrome	5.49e-05	0.000214	CcSEcCtD
Norfloxacin—Rash—Carbamazepine—epilepsy syndrome	5.49e-05	0.000214	CcSEcCtD
Norfloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	5.48e-05	0.000214	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.47e-05	0.000213	CcSEcCtD
Norfloxacin—Insomnia—Pregabalin—epilepsy syndrome	5.47e-05	0.000213	CcSEcCtD
Norfloxacin—Nausea—Clonazepam—epilepsy syndrome	5.45e-05	0.000213	CcSEcCtD
Norfloxacin—Headache—Carbamazepine—epilepsy syndrome	5.45e-05	0.000213	CcSEcCtD
Norfloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	5.43e-05	0.000212	CcSEcCtD
Norfloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.43e-05	0.000212	CcSEcCtD
Norfloxacin—Nausea—Phenytoin—epilepsy syndrome	5.42e-05	0.000211	CcSEcCtD
Norfloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	5.39e-05	0.00021	CcSEcCtD
Norfloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	5.39e-05	0.00021	CcSEcCtD
Norfloxacin—Vision blurred—Topiramate—epilepsy syndrome	5.38e-05	0.00021	CcSEcCtD
Norfloxacin—Somnolence—Pregabalin—epilepsy syndrome	5.37e-05	0.00021	CcSEcCtD
Norfloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.36e-05	0.000209	CcSEcCtD
Norfloxacin—Tremor—Topiramate—epilepsy syndrome	5.35e-05	0.000209	CcSEcCtD
Norfloxacin—Vomiting—Lamotrigine—epilepsy syndrome	5.35e-05	0.000209	CcSEcCtD
Norfloxacin—Urticaria—Valproic Acid—epilepsy syndrome	5.31e-05	0.000207	CcSEcCtD
Norfloxacin—Rash—Lamotrigine—epilepsy syndrome	5.3e-05	0.000207	CcSEcCtD
Norfloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	5.3e-05	0.000207	CcSEcCtD
Norfloxacin—Body temperature increased—Valproic Acid—epilepsy syndrome	5.29e-05	0.000206	CcSEcCtD
Norfloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	5.29e-05	0.000206	CcSEcCtD
Norfloxacin—Anorexia—Gabapentin—epilepsy syndrome	5.28e-05	0.000206	CcSEcCtD
Norfloxacin—Headache—Lamotrigine—epilepsy syndrome	5.27e-05	0.000206	CcSEcCtD
Norfloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	5.25e-05	0.000205	CcSEcCtD
Norfloxacin—Agitation—Topiramate—epilepsy syndrome	5.25e-05	0.000205	CcSEcCtD
Norfloxacin—Fatigue—Pregabalin—epilepsy syndrome	5.21e-05	0.000203	CcSEcCtD
Norfloxacin—Nausea—Carbamazepine—epilepsy syndrome	5.17e-05	0.000202	CcSEcCtD
Norfloxacin—Constipation—Pregabalin—epilepsy syndrome	5.17e-05	0.000202	CcSEcCtD
Norfloxacin—Vertigo—Topiramate—epilepsy syndrome	5.13e-05	0.0002	CcSEcCtD
Norfloxacin—Leukopenia—Topiramate—epilepsy syndrome	5.11e-05	0.0002	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.05e-05	0.000197	CcSEcCtD
Norfloxacin—Palpitations—Topiramate—epilepsy syndrome	5.05e-05	0.000197	CcSEcCtD
Norfloxacin—Insomnia—Gabapentin—epilepsy syndrome	5.01e-05	0.000196	CcSEcCtD
Norfloxacin—Nausea—Lamotrigine—epilepsy syndrome	5e-05	0.000195	CcSEcCtD
Norfloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	4.98e-05	0.000194	CcSEcCtD
Norfloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	4.98e-05	0.000194	CcSEcCtD
Norfloxacin—Convulsion—Topiramate—epilepsy syndrome	4.95e-05	0.000193	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.94e-05	0.000193	CcSEcCtD
Norfloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	4.94e-05	0.000193	CcSEcCtD
Norfloxacin—Somnolence—Gabapentin—epilepsy syndrome	4.93e-05	0.000192	CcSEcCtD
Norfloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.93e-05	0.000192	CcSEcCtD
Norfloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	4.88e-05	0.00019	CcSEcCtD
Norfloxacin—Arthralgia—Topiramate—epilepsy syndrome	4.86e-05	0.00019	CcSEcCtD
Norfloxacin—Chest pain—Topiramate—epilepsy syndrome	4.86e-05	0.00019	CcSEcCtD
Norfloxacin—Myalgia—Topiramate—epilepsy syndrome	4.86e-05	0.00019	CcSEcCtD
Norfloxacin—Anxiety—Topiramate—epilepsy syndrome	4.85e-05	0.000189	CcSEcCtD
Norfloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	4.82e-05	0.000188	CcSEcCtD
Norfloxacin—Urticaria—Pregabalin—epilepsy syndrome	4.8e-05	0.000187	CcSEcCtD
Norfloxacin—Asthenia—Valproic Acid—epilepsy syndrome	4.8e-05	0.000187	CcSEcCtD
Norfloxacin—Fatigue—Gabapentin—epilepsy syndrome	4.78e-05	0.000186	CcSEcCtD
Norfloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	4.78e-05	0.000186	CcSEcCtD
Norfloxacin—Body temperature increased—Pregabalin—epilepsy syndrome	4.78e-05	0.000186	CcSEcCtD
Norfloxacin—Dry mouth—Topiramate—epilepsy syndrome	4.76e-05	0.000186	CcSEcCtD
Norfloxacin—Constipation—Gabapentin—epilepsy syndrome	4.74e-05	0.000185	CcSEcCtD
Norfloxacin—Pruritus—Valproic Acid—epilepsy syndrome	4.73e-05	0.000185	CcSEcCtD
Norfloxacin—Confusional state—Topiramate—epilepsy syndrome	4.7e-05	0.000183	CcSEcCtD
Norfloxacin—Oedema—Topiramate—epilepsy syndrome	4.66e-05	0.000182	CcSEcCtD
Norfloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	4.57e-05	0.000178	CcSEcCtD
Norfloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	4.57e-05	0.000178	CcSEcCtD
Norfloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	4.57e-05	0.000178	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.53e-05	0.000177	CcSEcCtD
Norfloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	4.51e-05	0.000176	CcSEcCtD
Norfloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	4.45e-05	0.000174	CcSEcCtD
Norfloxacin—Anorexia—Topiramate—epilepsy syndrome	4.44e-05	0.000173	CcSEcCtD
Norfloxacin—Dizziness—Valproic Acid—epilepsy syndrome	4.42e-05	0.000172	CcSEcCtD
Norfloxacin—Urticaria—Gabapentin—epilepsy syndrome	4.4e-05	0.000172	CcSEcCtD
Norfloxacin—Body temperature increased—Gabapentin—epilepsy syndrome	4.38e-05	0.000171	CcSEcCtD
Norfloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	4.38e-05	0.000171	CcSEcCtD
Norfloxacin—Asthenia—Pregabalin—epilepsy syndrome	4.34e-05	0.000169	CcSEcCtD
Norfloxacin—Pruritus—Pregabalin—epilepsy syndrome	4.28e-05	0.000167	CcSEcCtD
Norfloxacin—Vomiting—Valproic Acid—epilepsy syndrome	4.25e-05	0.000166	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.25e-05	0.000166	CcSEcCtD
Norfloxacin—Insomnia—Topiramate—epilepsy syndrome	4.22e-05	0.000165	CcSEcCtD
Norfloxacin—Rash—Valproic Acid—epilepsy syndrome	4.22e-05	0.000164	CcSEcCtD
Norfloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	4.21e-05	0.000164	CcSEcCtD
Norfloxacin—Headache—Valproic Acid—epilepsy syndrome	4.19e-05	0.000163	CcSEcCtD
Norfloxacin—Paraesthesia—Topiramate—epilepsy syndrome	4.19e-05	0.000163	CcSEcCtD
Norfloxacin—Dyspnoea—Topiramate—epilepsy syndrome	4.16e-05	0.000162	CcSEcCtD
Norfloxacin—Somnolence—Topiramate—epilepsy syndrome	4.15e-05	0.000162	CcSEcCtD
Norfloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	4.14e-05	0.000161	CcSEcCtD
Norfloxacin—Dyspepsia—Topiramate—epilepsy syndrome	4.1e-05	0.00016	CcSEcCtD
Norfloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	4.08e-05	0.000159	CcSEcCtD
Norfloxacin—Decreased appetite—Topiramate—epilepsy syndrome	4.05e-05	0.000158	CcSEcCtD
Norfloxacin—Fatigue—Topiramate—epilepsy syndrome	4.02e-05	0.000157	CcSEcCtD
Norfloxacin—Dizziness—Pregabalin—epilepsy syndrome	4e-05	0.000156	CcSEcCtD
Norfloxacin—Constipation—Topiramate—epilepsy syndrome	3.99e-05	0.000156	CcSEcCtD
Norfloxacin—Asthenia—Gabapentin—epilepsy syndrome	3.98e-05	0.000155	CcSEcCtD
Norfloxacin—Nausea—Valproic Acid—epilepsy syndrome	3.97e-05	0.000155	CcSEcCtD
Norfloxacin—Pruritus—Gabapentin—epilepsy syndrome	3.92e-05	0.000153	CcSEcCtD
Norfloxacin—Vomiting—Pregabalin—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Norfloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	3.84e-05	0.00015	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.81e-05	0.000149	CcSEcCtD
Norfloxacin—Rash—Pregabalin—epilepsy syndrome	3.81e-05	0.000149	CcSEcCtD
Norfloxacin—Dermatitis—Pregabalin—epilepsy syndrome	3.81e-05	0.000149	CcSEcCtD
Norfloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	3.79e-05	0.000148	CcSEcCtD
Norfloxacin—Headache—Pregabalin—epilepsy syndrome	3.79e-05	0.000148	CcSEcCtD
Norfloxacin—Urticaria—Topiramate—epilepsy syndrome	3.7e-05	0.000145	CcSEcCtD
Norfloxacin—Abdominal pain—Topiramate—epilepsy syndrome	3.69e-05	0.000144	CcSEcCtD
Norfloxacin—Body temperature increased—Topiramate—epilepsy syndrome	3.69e-05	0.000144	CcSEcCtD
Norfloxacin—Dizziness—Gabapentin—epilepsy syndrome	3.67e-05	0.000143	CcSEcCtD
Norfloxacin—Nausea—Pregabalin—epilepsy syndrome	3.59e-05	0.00014	CcSEcCtD
Norfloxacin—Vomiting—Gabapentin—epilepsy syndrome	3.52e-05	0.000137	CcSEcCtD
Norfloxacin—Rash—Gabapentin—epilepsy syndrome	3.49e-05	0.000136	CcSEcCtD
Norfloxacin—Dermatitis—Gabapentin—epilepsy syndrome	3.49e-05	0.000136	CcSEcCtD
Norfloxacin—Headache—Gabapentin—epilepsy syndrome	3.47e-05	0.000135	CcSEcCtD
Norfloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	3.44e-05	0.000134	CcSEcCtD
Norfloxacin—Asthenia—Topiramate—epilepsy syndrome	3.35e-05	0.000131	CcSEcCtD
Norfloxacin—Pruritus—Topiramate—epilepsy syndrome	3.3e-05	0.000129	CcSEcCtD
Norfloxacin—Nausea—Gabapentin—epilepsy syndrome	3.29e-05	0.000128	CcSEcCtD
Norfloxacin—Diarrhoea—Topiramate—epilepsy syndrome	3.19e-05	0.000124	CcSEcCtD
Norfloxacin—Dizziness—Topiramate—epilepsy syndrome	3.08e-05	0.00012	CcSEcCtD
Norfloxacin—Vomiting—Topiramate—epilepsy syndrome	2.96e-05	0.000116	CcSEcCtD
Norfloxacin—Rash—Topiramate—epilepsy syndrome	2.94e-05	0.000115	CcSEcCtD
Norfloxacin—Dermatitis—Topiramate—epilepsy syndrome	2.94e-05	0.000115	CcSEcCtD
Norfloxacin—Headache—Topiramate—epilepsy syndrome	2.92e-05	0.000114	CcSEcCtD
Norfloxacin—Nausea—Topiramate—epilepsy syndrome	2.77e-05	0.000108	CcSEcCtD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.61e-05	0.000325	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AQP1—epilepsy syndrome	1.6e-05	0.000323	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	1.59e-05	0.000321	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.56e-05	0.000315	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.55e-05	0.000312	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	1.54e-05	0.00031	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GBE1—epilepsy syndrome	1.54e-05	0.00031	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	1.53e-05	0.000308	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.52e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	1.51e-05	0.000305	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.5e-05	0.000303	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	1.49e-05	0.0003	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AQP1—epilepsy syndrome	1.47e-05	0.000296	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	1.45e-05	0.000292	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	1.45e-05	0.000292	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALAD—epilepsy syndrome	1.45e-05	0.000292	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NT5E—epilepsy syndrome	1.45e-05	0.000292	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	1.44e-05	0.000291	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	1.41e-05	0.000283	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.39e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.39e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.39e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.39e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.38e-05	0.000279	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.38e-05	0.000279	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NT5E—epilepsy syndrome	1.37e-05	0.000276	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALAD—epilepsy syndrome	1.37e-05	0.000276	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.35e-05	0.000273	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	1.33e-05	0.000268	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	1.33e-05	0.000268	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.33e-05	0.000267	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	1.31e-05	0.000263	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	1.31e-05	0.000263	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.3e-05	0.000262	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.29e-05	0.000261	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.29e-05	0.000261	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.29e-05	0.00026	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	1.28e-05	0.000258	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	1.28e-05	0.000257	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADSL—epilepsy syndrome	1.25e-05	0.000252	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GLUL—epilepsy syndrome	1.23e-05	0.000248	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.22e-05	0.000245	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	1.21e-05	0.000243	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	1.19e-05	0.000241	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	1.18e-05	0.000238	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.18e-05	0.000238	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.17e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AQP1—epilepsy syndrome	1.16e-05	0.000234	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	1.15e-05	0.000232	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	1.14e-05	0.000231	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	1.13e-05	0.000227	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.13e-05	0.000227	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.12e-05	0.000226	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AQP1—epilepsy syndrome	1.09e-05	0.000221	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	1.08e-05	0.000218	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.07e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.07e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.07e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.07e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	1.06e-05	0.000213	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.05e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.05e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.05e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.05e-05	0.000212	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	1.05e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	1.05e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	1.05e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	1.03e-05	0.000208	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.01e-05	0.000204	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.97e-06	0.000201	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.97e-06	0.000201	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9.94e-06	0.0002	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	9.9e-06	0.0002	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	9.9e-06	0.0002	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	9.83e-06	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	9.8e-06	0.000197	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	9.8e-06	0.000197	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BCHE—epilepsy syndrome	9.79e-06	0.000197	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.57e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	9.47e-06	0.000191	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—COX3—epilepsy syndrome	9.38e-06	0.000189	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	9.34e-06	0.000188	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	9.24e-06	0.000186	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.22e-06	0.000186	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	9.21e-06	0.000186	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TH—epilepsy syndrome	9.21e-06	0.000186	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.03e-06	0.000182	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	9.01e-06	0.000182	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BCHE—epilepsy syndrome	8.97e-06	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	8.96e-06	0.000181	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.89e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.89e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.89e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.89e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.89e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	8.73e-06	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	8.73e-06	0.000176	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	8.56e-06	0.000173	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	8.54e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	8.47e-06	0.000171	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TH—epilepsy syndrome	8.44e-06	0.00017	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	8.33e-06	0.000168	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	8.33e-06	0.000168	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	8.32e-06	0.000168	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	8.27e-06	0.000167	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	8.15e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	8.13e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	8.13e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	8.13e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	8.07e-06	0.000163	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	7.98e-06	0.000161	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	7.86e-06	0.000159	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	7.83e-06	0.000158	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.83e-06	0.000158	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	7.82e-06	0.000158	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.76e-06	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.69e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	7.68e-06	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAT—epilepsy syndrome	7.58e-06	0.000153	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.56e-06	0.000152	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.56e-06	0.000152	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	7.47e-06	0.000151	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	7.37e-06	0.000149	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	7.19e-06	0.000145	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.11e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	7.11e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BCHE—epilepsy syndrome	7.08e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.07e-06	0.000143	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	7.05e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	7.04e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.98e-06	0.000141	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAT—epilepsy syndrome	6.95e-06	0.00014	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.91e-06	0.000139	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPX1—epilepsy syndrome	6.86e-06	0.000138	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	6.76e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	6.75e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.74e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.74e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	6.71e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.7e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BCHE—epilepsy syndrome	6.69e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	6.68e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TH—epilepsy syndrome	6.65e-06	0.000134	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.43e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.43e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	6.38e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	6.31e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	6.31e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	6.31e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.29e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TH—epilepsy syndrome	6.29e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPX1—epilepsy syndrome	6.28e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.19e-06	0.000125	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.16e-06	0.000124	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.04e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AGT—epilepsy syndrome	6.01e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.93e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOE—epilepsy syndrome	5.89e-06	0.000119	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.88e-06	0.000118	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.76e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	5.55e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.55e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AGT—epilepsy syndrome	5.51e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAT—epilepsy syndrome	5.48e-06	0.00011	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOE—epilepsy syndrome	5.4e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.39e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	5.33e-06	0.000107	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	5.25e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAT—epilepsy syndrome	5.18e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.15e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—POMC—epilepsy syndrome	5.06e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	5.04e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.01e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.98e-06	0.0001	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPX1—epilepsy syndrome	4.96e-06	9.99e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.95e-06	9.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.87e-06	9.82e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.87e-06	9.82e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPX1—epilepsy syndrome	4.68e-06	9.44e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—POMC—epilepsy syndrome	4.64e-06	9.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—epilepsy syndrome	4.61e-06	9.3e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.51e-06	9.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.5e-06	9.07e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AGT—epilepsy syndrome	4.35e-06	8.76e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.28e-06	8.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.26e-06	8.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOE—epilepsy syndrome	4.26e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—epilepsy syndrome	4.23e-06	8.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AGT—epilepsy syndrome	4.11e-06	8.28e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.07e-06	8.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	4.04e-06	8.14e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.02e-06	8.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOE—epilepsy syndrome	4.02e-06	8.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TH—epilepsy syndrome	4.01e-06	8.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.97e-06	8.01e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.95e-06	7.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.87e-06	7.8e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.85e-06	7.75e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	3.7e-06	7.46e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—POMC—epilepsy syndrome	3.66e-06	7.37e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.47e-06	7e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—POMC—epilepsy syndrome	3.46e-06	6.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.35e-06	6.74e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALB—epilepsy syndrome	3.33e-06	6.72e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.3e-06	6.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.3e-06	6.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.29e-06	6.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.21e-06	6.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—epilepsy syndrome	3.15e-06	6.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.14e-06	6.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.1e-06	6.26e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TH—epilepsy syndrome	3.09e-06	6.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.99e-06	6.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.92e-06	5.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	2.76e-06	5.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.62e-06	5.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.58e-06	5.21e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.56e-06	5.17e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.55e-06	5.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.48e-06	5e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.3e-06	4.64e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.2e-06	4.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—epilepsy syndrome	2.03e-06	4.09e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.02e-06	4.07e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.01e-06	4.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.98e-06	3.99e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.86e-06	3.75e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	3.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.7e-06	3.43e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.55e-06	3.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.47e-06	2.96e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.39e-06	2.79e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.36e-06	2.73e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.83e-07	1.78e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.82e-07	1.37e-05	CbGpPWpGaD
